APHA applauds FDA's first steps to address tobacco-related products

Date: Apr 25 2014

Statement by American Public Health Association Executive Director Georges Benjamin, MD

For more information, call APHA Communications at 202-777-3913 or email us.

WASHINGTON, D.C. — “On behalf of APHA I applaud the U.S. Food and Drug Administration for taking first steps toward addressing the potential harm presented by e-cigarettes and other unregulated tobacco products. FDA’s long-awaited decision tackles a critical gap in protecting children’s health nationwide.

“We’ve seen an alarming growth in the use of e-cigarettes among our youth, which may encourage conventional cigarette smoking among American children. This is a big public health concern. Despite great advancements in preventing the spread of tobacco addiction, tobacco use remains the leading cause of preventable death in this country, killing 480,000 people every year.

“While more evidence is necessary to know the full impact of e-cigarettes, FDA has opened a necessary pathway to acting faster when these risks are understood. I urge FDA to move forward without delay to protect our kids from the serious health risks of all tobacco and tobacco-related products.”

For more about APHA, visit www.apha.org.

# # #

The American Public Health Association champions the health of all people and all communities. We strengthen the profession of public health, share the latest research and information, promote best practices and advocate for public health issues and policies grounded in research. We are the only organization that combines a 140-plus year perspective, a broad-based member community and the ability to influence federal policy to improve the public’s health. Visit us at www.apha.org.